Key Data Updates and Treatment Trends in Ovarian Cancer From ASCO 2025

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss updates in ADCs and more in ovarian cancer from ASCO 2025.

EP. 1: Antibody-Drug Conjugates Could Continue to Reshape Ovarian Cancer Management

June 19th 2025

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss how ADCs could continue to reshape ovarian cancer management.

EP. 2: Data for First-Line Dostarlimab and Niraparib in Advanced Ovarian Cancer: The FIRST Trial

June 26th 2025

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss data for dostarlimab plus niraparib in advanced ovarian cancer.

EP. 3: TRUST Trial: Outcomes With Radical Up-Front Surgery in Advanced Ovarian Cancer

July 15th 2025

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss data for radical up-front surgery in advanced ovarian cancer from the TRUST trial.

EP. 4: Relacorilant Plus Nab-Paclitaxel in Platinum-Resistant Ovarian Cancer: The ROSELLA Trial

July 17th 2025

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss data for relacorilant plus nab-paclitaxel in platinum-resistant ovarian cancer.

EP. 5: Findings for Neoadjuvant IMNN-001 Plus Chemo in Newly Diagnosed, Advanced Epithelial Ovarian Cancer

July 22nd 2025

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss data for neoadjuvant IMNN-001 plus chemotherapy in advanced epithelial ovarian cancer.

EP. 6: Ongoing Research to Watch in Ovarian Cancer in 2025 and Beyond

July 29th 2025

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss ongoing research to watch in ovarian cancer.